Celcuity soared more than 200% before the market, and the company's experimental therapy can delay the spread of breast cancer

Celcuity's experimental combination treatment helps delay progress in advanced breast cancer trials, and its stock soars more than 200% premarket
Related stocks
 
Related News

Biotech firm Celcuity surges 210% in early session

格隆汇·7月 28, 2025
Biotech firm Celcuity surges 210% in early session

Opening | celcuity soared more than 220%, AEye rose more than 28%, and Ethereum concept stocks strengthened

老虎资讯综合·7月 28, 2025
Opening | celcuity soared more than 220%, AEye rose more than 28%, and Ethereum concept stocks strengthened

Pre-market | celcuity rose more than 200%, AEye continued to be strong, WeRide rose more than 7%

老虎资讯综合·7月 28, 2025
Pre-market | celcuity rose more than 200%, AEye continued to be strong, WeRide rose more than 7%

Interpretation of changes | Celcuity's stock price soared 241.87% before the market opened, and the new breast cancer drug trial data was eye-catching

异动解读·7月 28, 2025
Interpretation of changes | Celcuity's stock price soared 241.87% before the market opened, and the new breast cancer drug trial data was eye-catching

Celcuity jumps 206% premarket

格隆汇·7月 28, 2025
Celcuity jumps 206% premarket

Celcuity jumps 206% premarket

格隆汇·7月 28, 2025
Celcuity jumps 206% premarket

Celcuity soared 220%, the company's experimental therapy can delay the spread of breast cancer

老虎资讯综合·7月 28, 2025
Celcuity soared 220%, the company's experimental therapy can delay the spread of breast cancer

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10